U.S. Markets

FDA authorizes ZYN ULTRA nicotine pouches following scientific review

StockNow breaking-news AI analysis

FDA authorized ZYN products under modified risk guidelines, while Philip Morris expands production capacity amid rising competition from BAT's Velo and tightening global regulations.

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more